We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: Family Medicine & Nutrition

Low-Dose Caffeine Boosts Cognitive Function but Not Physical Performance in Fatigued Taekwondo Athletes: Insights from a Randomized Crossover Trial

MedXY Editorial Team•Oct 5, 2025•Family Medicine & Nutrition
caffeinecognitive functionfatiguePhysical Performance

Highlight

  • Low-dose caffeine (200 mg) reduces cortical drowsiness reflected by decreased delta wave power shortly after ingestion in fatigued Taekwondo athletes.
  • Caffeine enhances cognitive processing as demonstrated by increased P300 amplitude in auditory event-related potentials post fatigue induction.
  • No significant caffeine-induced improvements were observed in sport-specific physical performance or physiological fatigue markers after combined mental and physical fatigue.
  • Findings suggest caffeine’s primary beneficial effect post-fatigue lies in cognitive enhancement rather than physical performance amplification in combat sports.

Study Background and Disease Burden

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Patient Perspectives on Prolactinoma in Females: Insights from the Dutch Cohort StudiesA large Dutch cohort study reveals fatigue and cognitive impairment as predominant symptoms in females with prolactinoma, with active disease linked to higher psychological burden despite dopamine agonist treatment.Sep 1, 2026Long-Term Fatigue in Differentiated Thyroid Cancer Survivors: Early Predictors and the Non-Impact of Thyrotropin SuppressionA nationwide prospective study identifies early fatigue and poor mental health as key predictors of long-term fatigue in differentiated thyroid cancer patients, while thyrotropin suppression shows no association with fatigue.Aug 21, 2026Metabolomic Clock Links Plasma Metabolites to Ageing, Frailty, and Cognitive DeclineA metabolomic clock based on plasma metabolites accurately estimated chronological age (r=0.92) and was associated with mortality, frailty, and cognitive impairment across two European cohorts.Jul 26, 2026Fatigue After Thyroidectomy: What Patients Actually Experience
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
A qualitative study found that fatigue after thyroidectomy is common, disruptive, and often unexpected. Patients described major impacts on work and daily life, and many wanted surgeons to warn them about it before surgery.
May 20, 2026
Optimal Sleep Duration Mitigates Cognitive Decline and Dementia Risk in Focal Epilepsy: Insights from the UK Biobank StudyA UK Biobank study reveals that optimal sleep (6-8 hours) improves executive function and reduces dementia risk in focal epilepsy patients, with effects surpassing those in stroke patients. Nonoptimal sleep exacerbates cognitive deficits upApr 25, 2026
Fluvoxamine Shows Promise for Treating Long COVID Fatigue: Results from Adaptive Randomized TrialA randomized trial of 399 adults with long COVID fatigue found that fluvoxamine significantly reduced fatigue severity at 60 and 90 days compared to placebo, while metformin showed no benefit. The study represents a potential breakthrough iApr 3, 2026